A new methodology combining small molecules and phage-displayed peptides enables the isolation of chemically modified bicyclic peptides capable of high-affinity recognition of target proteins.
References
Walsh, G. Nat. Biotechnol. 24, 769–776 (2006).
McCafferty, J., Griffiths, A.D., Winter, G. & Chiswell, D. Nature 348, 552–554 (1990).
Clackson, T., Hoogenboom, H.R., Griffiths, A.D. & Winter, G. Nature 352, 624–628 (1991).
Winter, G., Griffiths, A.D., Hawkins, R.E. & Hoogenboom, H.R. Annu. Rev. Immunol. 12, 433–455 (1994).
Kang, A.S., Barbas, C.F., Janda, K.D., Benkovic, S.J. & Lerner, R.A. Proc. Natl. Acad. Sci. USA 88, 4363–4366 (1991).
Heinis, C., Rutherford, T., Freund, S. & Winter, G. Nat. Chem. Biol. 5, 502–507 (2009).
Brenner, S. & Lerner, R.A. Proc. Natl. Acad. Sci. USA 89, 5381–5383 (1992).
Gartner, Z.J. et al. Science 305, 1601–1605 (2004).
Halpin, D.R. & Harbury, P.B. PLoS Biol. 2, E174 (2004).
Melkko, S., Scheuermann, J., Dumelin, C.E. & Neri, D. Nat. Biotechnol. 22, 568–574 (2004).
Mannocci, L. et al. Proc. Natl. Acad. Sci. USA 105, 17670–17675 (2008).
Smith, G.P. Science 228, 1315–1317 (1985).
Low, P.S., Henne, W.A. & Doorneweerd, D.D. Acc. Chem. Res. 41, 120–129 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
D.N. is a cofounder and shareholder of Philogen (www.philogen.com), a company that develops biotech products originating from phage display libraries and DNA-encoded chemical libraries.
Rights and permissions
About this article
Cite this article
Neri, D., Brändli, A. Encoding chemistry. Nat Chem Biol 5, 452–453 (2009). https://doi.org/10.1038/nchembio0709-452
Issue Date:
DOI: https://doi.org/10.1038/nchembio0709-452
- Springer Nature America, Inc.